PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Phase III, multicentre, randomized, double-blind, parallel group, long-term study investigating the efficacy and safety of the 5mg and 10mg doses of PGL4001 for the treatment of uterine myoma.
Epistemonikos ID: fdcb25f22d98bf4b8de0f8c27666db0d0c41ca55
First added on: May 11, 2024